These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30174434)

  • 21. First Innovative Medicines Initiative Ebola projects launched.
    Eurosurveillance editorial team
    Euro Surveill; 2015 Jan; 20(3):. PubMed ID: 25635321
    [No Abstract]   [Full Text] [Related]  

  • 22. Public-Private Partnerships in Lead Discovery: Overview and Case Studies.
    Gottwald M; Becker A; Bahr I; Mueller-Fahrnow A
    Arch Pharm (Weinheim); 2016 Sep; 349(9):692-7. PubMed ID: 27335205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The rational use of animals in drug development: contribution of the innovative medicines initiative.
    Magda G; Vaudano E; Goldman M
    Altern Lab Anim; 2012 Dec; 40(6):307-12. PubMed ID: 23398335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orphan Medicines for Pediatric Use: A Focus on the European Union.
    Bolislis WR; Corriol-Rohou S; Hill-Venning C; Hoogland H; Joos A; King D; Kitcatt V; Le Visage G; Kühler TC
    Clin Ther; 2019 Dec; 41(12):2630-2642. PubMed ID: 31704041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brand-specific estimates of influenza vaccine effectiveness for the 2021-2022 season in Europe: results from the DRIVE multi-stakeholder study platform.
    Stuurman AL; Carmona A; Biccler J; Descamps A; Levi M; Baum U; Mira-Iglesias A; Bellino S; Hoang U; de Lusignan S; Bonaiuti R; Lina B; Rizzo C; Nohynek H; Díez-Domingo J;
    Front Public Health; 2023; 11():1195409. PubMed ID: 37546295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoting transparency, accountability, and access through a multi-stakeholder initiative: lessons from the medicines transparency alliance.
    Vian T; Kohler JC; Forte G; Dimancesco D
    J Pharm Policy Pract; 2017; 10():18. PubMed ID: 28588896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Children's Vaccine Initiative and vaccine supply: the role of the public sector.
    van Noort RB
    Vaccine; 1992; 10(13):909-10. PubMed ID: 1471410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
    Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
    Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to Implementation.
    Schulthess D; Baird LG; Trusheim M; Unger TF; Lumpkin M; Hoos A; Garner S; Gavin P; Goldman M; Seigneuret N; Chlebus M; Van Baelen K; Bergstrom R; Hirsch G
    Ther Innov Regul Sci; 2016 May; 50(3):347-354. PubMed ID: 30227070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. European initiative towards quality standards in education and training for discovery, development and use of medicines.
    Klech H; Brooksbank C; Price S; Verpillat P; Bühler FR; Dubois D; Haider N; Johnson C; Lindén HH; Payton T; Renn O; See W
    Eur J Pharm Sci; 2012 Apr; 45(5):515-20. PubMed ID: 22178534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enabling personalized medicine in Europe by the European Commission's funding activities.
    Nimmesgern E; Norstedt I; Draghia-Akli R
    Per Med; 2017 Jul; 14(4):355-365. PubMed ID: 29749834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving R&D productivity of pharmaceutical companies through public-private partnership: experiences from the Innovative Medicines Initiative.
    Laverty H; Gunn M; Goldman M
    Expert Rev Pharmacoecon Outcomes Res; 2012 Oct; 12(5):545-8. PubMed ID: 23136843
    [No Abstract]   [Full Text] [Related]  

  • 33. Powered by Open Innovation: Opportunities and Challenges in the Pharma Sector.
    Martinez-Grau MA; Alvim-Gaston M
    Pharmaceut Med; 2019 Jun; 33(3):193-198. PubMed ID: 31933287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Innovation Partnership for a Roadmap on Vaccines in Europe (IPROVE): A vision for the vaccines of tomorrow.
    Medaglini D; De Azero MR; Leroy O; Bietrix F; Denoel P
    Vaccine; 2018 Feb; 36(9):1136-1145. PubMed ID: 29395517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consensus document on European brain research.
    Olesen J; Baker MG; Freund T; di Luca M; Mendlewicz J; Ragan I; Westphal M
    J Neurol Neurosurg Psychiatry; 2006 Aug; 77 Suppl 1(Suppl 1):i1-49. PubMed ID: 16845120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New safe medicines faster: A proposal for a key action within the European union's 6th framework programme.
    Bjerrum OJ
    Pharmacol Toxicol; 2000; 86 Suppl 1():23-6. PubMed ID: 10905750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A European arena for joint innovation in healthcare: The Platform for Innovation of Procurement and Procurement of Innovation (PiPPi).
    Andrews MR; Long PA; Ahlberg M; Balvert F; Alessandrello R; Lazzari A; Timmermann MM; Nouri Janian M; Rantaniska M; Spence A; Söderman P; Valls-Comamala V; Stamm T
    Front Public Health; 2022; 10():1000590. PubMed ID: 36711358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The European Prevention of Alzheimer's Dementia Programme: An Innovative Medicines Initiative-funded partnership to facilitate secondary prevention of Alzheimer's disease dementia.
    Saunders S; Gregory S; Clement MHS; Birck C; van der Geyten S; Ritchie CW
    Front Neurol; 2022; 13():1051543. PubMed ID: 36484017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UK medicines regulation: responding to current challenges.
    Richards N; Hudson I
    Br J Clin Pharmacol; 2016 Dec; 82(6):1471-1476. PubMed ID: 27580254
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.